The dapagliflozin had therapeutic effects on decreasing proteinuria and increasing serum albumin in short-term treatment in children with hereditary proteinuric kidney disease, no hypoglycemia or serious adverse events were observed.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2023) studied this question.